ASSERTIO HOLDINGS INC (ASRT) Stock Price, Quote, News and Overview
NASDAQ:ASRT - Nasdaq - US04546C2052 - Common Stock - Currency: USD
ASRT Quote, Performance and Key Statistics
NASDAQ:ASRT (2/26/2025, 10:16:30 AM)
0.81
+0.02 (+2.53%)
The current stock price of ASRT is 0.81 USD. In the past month the price decreased by -2.02%. In the past year, price decreased by -10.07%.
ASRT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 70.06 | 864.56B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 28 | 400.23B | ||
| JNJ | JOHNSON & JOHNSON | 16.37 | 393.80B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 21.06 | 235.75B | ||
| MRK | MERCK & CO. INC. | 11.77 | 227.52B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.68 | 214.47B | ||
| PFE | PFIZER INC | 8.56 | 150.86B | ||
| SNY | SANOFI-ADR | 13.63 | 137.41B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 50.97 | 117.86B | ||
| GSK | GSK PLC-SPON ADR | 7.99 | 76.76B | ||
| ZTS | ZOETIS INC | 28.44 | 75.96B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 32.63 | 45.51B |
Related stock screener links
About ASRT
Company Profile
Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The company is headquartered in Lake Forest, Illinois and currently employs 53 full-time employees. The firm has built its commercial portfolio through acquisition or licensing of approved products. Its comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipsor (diclofenac potassium) Liquid filled capsules. INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID).
Company Info
ASSERTIO HOLDINGS INC
100 S. Saunders Road, Suite 300
Lake Forest ILLINOIS 60045 US
CEO: Daniel A. Peisert
Employees: 53
Company Website: https://www.assertiotx.com/
Investor Relations: https://investor.assertiotx.com/overview/default.aspx
Phone: 12244197106
ASSERTIO HOLDINGS INC / ASRT FAQ
What is the stock price of ASSERTIO HOLDINGS INC today?
The current stock price of ASRT is 0.81 USD. The price increased by 2.53% in the last trading session.
What is the ticker symbol for ASSERTIO HOLDINGS INC stock?
The exchange symbol of ASSERTIO HOLDINGS INC is ASRT and it is listed on the Nasdaq exchange.
On which exchange is ASRT stock listed?
ASRT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ASSERTIO HOLDINGS INC stock?
10 analysts have analysed ASRT and the average price target is 3.09 USD. This implies a price increase of 281.56% is expected in the next year compared to the current price of 0.81. Check the ASSERTIO HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ASSERTIO HOLDINGS INC worth?
ASSERTIO HOLDINGS INC (ASRT) has a market capitalization of 77.34M USD. This makes ASRT a Micro Cap stock.
How many employees does ASSERTIO HOLDINGS INC have?
ASSERTIO HOLDINGS INC (ASRT) currently has 53 employees.
What are the support and resistance levels for ASSERTIO HOLDINGS INC (ASRT) stock?
ASSERTIO HOLDINGS INC (ASRT) has a resistance level at 0.8. Check the full technical report for a detailed analysis of ASRT support and resistance levels.
Is ASSERTIO HOLDINGS INC (ASRT) expected to grow?
The Revenue of ASSERTIO HOLDINGS INC (ASRT) is expected to decline by -20.57% in the next year. Check the estimates tab for more information on the ASRT EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ASSERTIO HOLDINGS INC (ASRT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ASRT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ASRT, evaluating the profitability, health, valuation and growth aspects
- ASSERTIO HOLDINGS INC (ASRT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ASSERTIO HOLDINGS INC (ASRT) Sales and EPS estimates to see what analysts future expectations are.
- ASSERTIO HOLDINGS INC (ASRT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ASSERTIO HOLDINGS INC (ASRT) Insider and Institutional Ownership to learn about the owners and their transactions.
- ASSERTIO HOLDINGS INC (ASRT) Stock Chart to make your own analysis
- ASSERTIO HOLDINGS INC (ASRT) Latest news and press-releases to stay up to date.
Does ASSERTIO HOLDINGS INC (ASRT) stock pay dividends?
ASRT does not pay a dividend.
When does ASSERTIO HOLDINGS INC (ASRT) report earnings?
ASSERTIO HOLDINGS INC (ASRT) will report earnings on 2025-03-05, after the market close.
What is the Price/Earnings (PE) ratio of ASSERTIO HOLDINGS INC (ASRT)?
ASSERTIO HOLDINGS INC (ASRT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.73).
What is the Short Interest ratio of ASSERTIO HOLDINGS INC (ASRT) stock?
The outstanding short interest for ASSERTIO HOLDINGS INC (ASRT) is 6.18% of its float. Check the ownership tab for more information on the ASRT short interest.
ASRT Technical Analysis
ASRT Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ASRT. While ASRT seems to be doing ok healthwise, there are quite some concerns on its profitability.
ASRT Financial Highlights
Over the last trailing twelve months ASRT reported a non-GAAP Earnings per Share(EPS) of -0.73. The EPS decreased by -177.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -24.81% | ||
| ROE | -52.47% | ||
| Debt/Equity | 0.3 |
ASRT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to ASRT. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of 84.04% and a revenue growth -20.57% for ASRT